SCHEMBL357498

SCHEMBL357498

Clc1nc(N2CCC2)c2nc(Cl)c(OCCc3ccccc3)nc2n1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 10/20 0.48
PDE4B Q07343 10/20 0.48
PDE4C Q08493 10/20 0.48
PDE4D Q08499 10/20 0.48
HRH4 Q9H3N8 2/20 0.45
PIN1 Q13526 1/20 0.41
MPO P05164 1/20 0.37
CNR2 P34972 1/20 0.36
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292370 0.85 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL292108 0.77 PDE4A (0.60) PDE4APDE4BPDE4CPDE4D
SCHEMBL15876480 0.76 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL291770 0.75 PDE4A (0.73) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL3095331 0.75 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL3957428 0.74 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL3322669 0.73 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL291929 0.72 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL11044198 0.71 HRH4 (0.43) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL1719503 0.69 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029600-B1 SUBSTITUTED PTERIDINES SUBSTITUTED WITH A FOUR-MEMBERED HETEROCYCLE BOEHRINGER INGELHEIM INT (DE) 2012-03-14 EP disclosed
US-20100234347-A1 Substituted Pteridines substituted with a Four-Membered Heterocycle BOEHRINGER INGELHEIM INTERNATIONL GMBH (DE) 2010-09-16 US disclosed
US-20100234347-A1 Substituted Pteridines substituted with a Four-Membered Heterocycle BOEHRINGER INGELHEIM INTERNATIONL GMBH (DE) 2010-09-16 US disclosed
US-20100234347-A1 Substituted Pteridines substituted with a Four-Membered Heterocycle BOEHRINGER INGELHEIM INTERNATIONL GMBH (DE) 2010-09-16 US disclosed
WO-2007135027-A1 SUBSTITUTED PTERIDINES SUBSTITUTED WITH A FOUR-MEMBERED HETEROCYCLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234347-A1 Substituted Pteridines substituted with a Four-Membered Heterocycle UACA, LTC4S, PMP22 PDE4A 1509/4885PDE4B 1446/4885PDE4C 1569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.